Pharmaceutical preparations; antibody preparations; monoclonal antibodies; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; proteins; recombinant antibodies; vaccines; all of the above aforesaid goods being for the diagnosis or treatment of amyloidosis.